We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+7.69%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$42.3B
AUM Growth
+$5.51B
(+15%)
Cap. Flow
+$3.13B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
26.06%
Holding
1,338
New
111
Increased
793
Reduced
350
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$238M |
| 2 |
CGAU
Centerra Gold
CGAU
|
+$212M |
| 3 |
Halliburton
HAL
|
+$181M |
| 4 |
Baker Hughes
BKR
|
+$115M |
| 5 |
ServiceNow
NOW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gold Fields
GFI
|
+$374M |
| 2 |
John Wiley & Sons Class A
WLY
|
+$96.5M |
| 3 |
Bank of America
BAC
|
+$90.9M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$89.1M |
| 5 |
US Bancorp
USB
|
+$84.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 40.42% |
| 2 | Technology | 21.38% |
| 3 | Energy | 8.67% |
| 4 | Healthcare | 6.57% |
| 5 | Financials | 3.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
ICU Medical
ICUI
$4.16B
| $49K | ﹤0.01% |
239
+128
| +115% | +$26.3K |
|
1202
Medifast
MED
$107M
| $49K | ﹤0.01% |
+173
| New | +$46.9K |
|
|
NXRT
1203
NexPoint Residential Trust
NXRT
$689M
| $49K | ﹤0.01% |
898
-16
| -2% | -$823 |
|
1204
Radian Group
RDN
$5.28B
| $49K | ﹤0.01% |
2,224
+1,211
| +120% | +$28.3K |
|
1205
WD-40
WDFC
$2.98B
| $49K | ﹤0.01% |
192
+108
| +129% | +$27.6K |
|
1206
First Hawaiian
FHB
$3.41B
| $48K | ﹤0.01% |
+1,687
| New | +$47.2K |
|
1207
Home BancShares
HOMB
$6.3B
| $47K | ﹤0.01% |
+1,891
| New | +$51K |
|
1208
Kinsale Capital Group
KNSL
$8.58B
| $47K | ﹤0.01% |
288
+165
| +134% | +$27.2K |
|
1209
Assured Guaranty
AGO
$3.73B
| $46K | ﹤0.01% |
+959
| New | +$45K |
|
1210
Qualys
QLYS
$4.76B
| $46K | ﹤0.01% |
457
+255
| +126% | +$26K |
|
|
CHCT
1211
Community Healthcare Trust
CHCT
$536M
| $45K | ﹤0.01% |
941
+14
| +2% | +$685 |
|
1212
Meritage Homes
MTH
$4.78B
| $45K | ﹤0.01% |
964
+542
| +128% | +$27.4K |
|
1213
Lincoln National
LNC
$7.92B
| $44K | ﹤0.01% |
697
+455
| +188% | +$30K |
|
|
UFS
1214
DELISTED
DOMTAR CORPORATION (New)
UFS
| $44K | ﹤0.01% |
803
+1
| +0.1% | +$48 |
|
1215
Ameris Bancorp
ABCB
$5.89B
| $43K | ﹤0.01% |
+842
| New | +$45.2K |
|
|
SAGE
1216
DELISTED
Sage Therapeutics
SAGE
| $43K | ﹤0.01% |
+755
| New | +$53.4K |
|
|
CSR
1217
Centerspace
CSR
$952M
| $42K | ﹤0.01% |
534
-7
| -1% | -$504 |
|
1218
SS&C Technologies
SSNC
$18.9B
| $42K | ﹤0.01% |
581
+383
| +193% | +$28K |
|
|
RPT
1219
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $42K | ﹤0.01% |
3,252
-104
| -3% | -$1.32K |
|
|
DISCK
1220
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $42K | ﹤0.01% |
1,464
+922
| +170% | +$28.6K |
|
1221
NetApp
NTAP
$34B
| $41K | ﹤0.01% |
503
+317
| +170% | +$24.8K |
|
|
DHC
1222
Diversified Healthcare Trust
DHC
$2.15B
| $40K | ﹤0.01% |
9,572
-292
| -3% | -$1.21K |
|
1223
Equitable Holdings
EQH
$13.2B
| $40K | ﹤0.01% |
1,325
+788
| +147% | +$25.7K |
|
1224
Open Text
OTEX
$6.28B
| $40K | ﹤0.01% |
791
+526
| +198% | +$25.4K |
|
|
INN
1225
Summit Hotel Properties
INN
$766M
| $39K | ﹤0.01% |
4,184
-117
| -3% | -$1.16K |
|
Similar funds
DAM
VanEck Associates's Q2 2021 Portfolio in Review
As of Q2 2021, VanEck Associates held 1,338 positions worth $42.3B, up 15% from $36.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
VanEck Associates deployed $3.13B of net new capital in Q2 2021, opening 111 new positions and adding to 793 existing holdings. Its largest new stake was Centerra Gold: 25,491,475 shares worth $193M.
By sector, the portfolio is most concentrated in Materials at 40% of assets, down from 43% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was Gold Fields, an estimated $374M trimmed.
- VanEck Associates's largest Q2 2021 buy was Centerra Gold: 25,491,475 shares worth $193M.
- VanEck Associates added most to SLB Ltd in Q2 2021, an estimated $238M increase.
- VanEck Associates's biggest Q2 2021 reduction was Gold Fields, cutting an estimated $374M.
- VanEck Associates fully exited John Wiley & Sons Class A in Q2 2021, selling an estimated $96.5M.
- VanEck Associates's ten largest holdings make up 26% of its $42.3B portfolio in Q2 2021.
- VanEck Associates opened 111 new positions and closed 65 in Q2 2021.
- VanEck Associates's portfolio value rose 15% quarter-over-quarter to $42.3B.
Based on VanEck Associates's 13F filing for Q2 2021, filed 10 Aug 2021.